Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 100/kg
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Fast Delivery
The supplier can deliver the goods within 15 days
Low MOQ
The MOQ for the supplier's products is 1
to see all verified strength labels (7)
  • Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
  • Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
  • Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
  • Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
  • Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
  • Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
Find Similar Products

Basic Info.

Model NO.
QH-Tranexamic Acid
Appearance
White
Sample
Available
Storage
Cool Dry Place
Shelf Life
2 Years
Transport Package
25kg/Drum
Specification
99%
Trademark
Qinhe
Origin
China
HS Code
0000
Production Capacity
99999kg/Weeks

Product Description

Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

Tranexamic acid is a derivative of aminomethylbenzoic acid, and a kind of antifibrinolytic drugs to stop bleeding. The hemostasis mechanism of tranexamic acid is similar to aminocaproic acid and aminomethylbenzoic acid, but the effect is stronger. The strength is 7 to 10 times of aminocaproic acid, 2 times of aminomethylbenzoic acid, but toxicity is similar.

The chemical structure of tranexamic acid is similar to lysine, competitive inhibition of plasmin original in fibrin adsorption, to prevent their activation, protection fiber protein not to degrade by plasmin and dissolve, eventually achieve hemostasis. Applicable in the treatment of acute or chronic, localized or systemic primary fiber fibrinolytic hyperthyroidism caused by bleeding, such as obstetric hemorrhage, renal hemorrhage, hemorrhage of hypertrophy of the prostate, hemophilia, pulmonary tuberculosis hemoptysis, stomach bleeding, after operation of liver, lung, spleen and other viscera hemorrhage; also can be used in surgery when abnormal bleeding etc..

Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

 

Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8
Analysi Specifications
Assay ≥99%
Appearance White
Loss on Drying ≤1.0%
Ash ≤1.0%
As ≤2.0ppm
Pb ≤2.0ppm
Insoluble impurity content ≤0.05%
Total Plate Count ≤1000 cfu/g
Yeast &. Mold ≤100 cfu/g
E.Coli Negative
Salmonella Negative
Conclusion
 
Conform USP Standard.
Storage condition
Store in cool & dry place, Keep away from strong light and heat.
Shelf life
2 years when properly stored.
Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8Stocks 99% Assay Pharmaceutical Material Tranexamic Acid CAS 1197-18-8

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier